Overview and Scope
Single-photon emission computed tomography (SPECT) is a medical imaging technique that uses radioactive tracers and gamma rays to produce 3D images of internal organs and tissues. The tracer can be detected by a gamma camera by emitting gamma rays, allowing for non-invasive and detailed imaging of a patient’s internal structure.
Sizing and Forecast
The single-photon emission computed tomography (spect) market size has grown strongly in recent years. It will grow from $2.27 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing diagnostic imaging needs, rising incidence of chronic diseases, advancements in radiopharmaceuticals, expanding aging population, increasing healthcare expenditure..
The single-photon emission computed tomography (spect) market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing emphasis on precision medicine, expanding applications in neurological imaging, global rise in cancer incidence, advancements in radiotracer development, integration into multimodal imaging systems.. Major trends in the forecast period include enhanced image reconstruction techniques, mobile spect imaging services, growing emphasis on cardiac imaging, innovations in detector technology, increasing clinical research initiatives..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report
Segmentation & Regional Insights
The single-photon emission computed tomography (spect) market covered in this report is segmented –
1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User
North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of cases of cancer is expected to propel the growth of the single-photon emission computed tomography (SPECT) market going forward. This rise in the number of cancer cases has resulted from a rise in the aging population, unhealthy lifestyle choices, and environmental factors. Single-photon emission computed tomography (SPECT) helps in the diagnosis, staging, and monitoring of cancer along with other imaging techniques like computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . Therefore, the rise in the prevalence of cases of cancer is driving the growth of the single-photon emission computed tomography (SPECT) market.
Key Industry Players
Major companies operating in Single-photon emission computed tomography (SPECT) are developing innovative products such as portable gamma camera to drive the revenues in the market. The clinical testing of a portable gamma camera indicates advancements in technology aimed at making SPECT imaging more accessible, versatile, and applicable in various healthcare scenarios. For instance, in June 2023, Serac Imaging, a UK-based molecular imaging company launched portable high resolution hybrid gamma optical camera. The device is designed to be complementary to the technology currently used in nuclear medicine departments and aims to simplify workflows and bring additional capacity.
The single-photon emission computed tomography (spect) market report table of contents includes:
1. Executive Summary
2. Single-Photon Emission Computed Tomography (SPECT) Market Characteristics
3. Single-Photon Emission Computed Tomography (SPECT) Market Trends And Strategies
4. Single-Photon Emission Computed Tomography (SPECT) Market – Macro Economic Scenario
5. Global Single-Photon Emission Computed Tomography (SPECT) Market Size and Growth
….
31. Global Single-Photon Emission Computed Tomography (SPECT) Market Competitive Benchmarking
32. Global Single-Photon Emission Computed Tomography (SPECT) Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Single-Photon Emission Computed Tomography (SPECT) Market
34. Single-Photon Emission Computed Tomography (SPECT) Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
